Microplasmas are nowadays a powerful tool with multiple practical applications. The performance of a specific instrumentation for a plasma needle capable of producing non-thermal plasmas and a DBD reactor able to produce atmospheric pressure plasmas, both of them designed and already constructed, is reported. These devices operate at 13.56 MHz and are driven by a specifically built radio frequency (RF) resonant converter. The reactors, which operate at atmospheric pressure in a He-air gas mixture at a 1.5 SLPM flow, have been successfully applied to eliminate E. coli bacteria. In the needle case, bacterial samples were submitted typically to a 500 V peak voltage plasma discharge for 120 s. In the DBD treatment, the samples were processed with typical 750 V peak voltage plasma discharges for 80 s. The sample pH was used as a criterion to measure the effectiveness of the plasma treatment, in such a way that the return to the basal pH value after the treatment can be assumed as the validation of the complete bacterial elimination.
No takes yet. Share an insight, caveat, or question.
Peña‐Eguiluz et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: